Disease Overview：Tumor Interventional Therapy（IO）
Tumor interventional therapy is a minimally invasive, image-guided treatment modality used primarily for solid malignancies—including hepatocellular carcinoma, renal cell carcinoma, lung cancer, and metastatic liver tumors—when surgical resection is contraindicated or suboptimal. It encompasses techniques such as transarterial chemoembolization (TACE), radiofrequency ablation (RFA), microwave ablation (MWA), cryoablation, and selective internal radiation therapy (SIRT/Y-90). These procedures target tumors with precision, delivering cytotoxic agents, thermal energy, or ionizing radiation directly to the lesion while sparing adjacent healthy tissue. Interventional oncology is particularly valuable for patients with intermediate-stage disease, recurrent tumors, or those unfit for systemic therapy due to comorbidities. Clinical evidence supports its role in improving progression-free survival, bridging to transplantation, and palliating symptoms—especially in hepatobiliary and pancreatic cancers where anatomical complexity limits surgical options.
China offers distinct advantages in tumor interventional therapy: its top-tier hospitals—such as Fudan University Shanghai Cancer Center and Sun Yat-sen University Cancer Center—house internationally trained interventional radiologists and oncologists with extensive experience in complex ablations and multimodal protocols. State-of-the-art equipment—including dual-energy CT, 3.0T MRI-guided ablation platforms, and real-time fusion imaging—is widely deployed across accredited centers. Published outcomes demonstrate high technical success rates (>92%) and favorable local tumor control, particularly in HCC and colorectal liver metastases. Crucially, costs are typically 40–60% lower than in the US or Western Europe, without compromising clinical standards or regulatory oversight (NMPA-approved devices and protocols). As a dedicated medical tourism agency, we facilitate seamless access for international patients: verifying hospital credentials, coordinating pre-arrival diagnostics, securing appointments with senior interventional oncologists, providing transparent all-inclusive pricing (covering procedure, imaging, pathology, and follow-up), and offering end-to-end support—from visa assistance and accommodation to bilingual care coordination and post-treatment monitoring.
Tumor Interventional Therapy: treatment in China helps patients compare specialist hospitals, initial assessment steps and estimated costs that may vary by city, institution and clinical condition.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Interventional Oncology (Tumor Interventional Therapy)
Non-Surgical / Conservative / Medication-Based Options
*Indicated for palliation, bridging to definitive therapy, or contraindications to invasive procedures.*
- •Transarterial Embolization (TAE) + Systemic Antiangiogenics (e.g., apatinib)
- *Fees (USD):* - Pre-procedure CT/MRI angiography: $180–$240 - Drug-eluting bead (DEB-TACE) kit (standard dose): $420–$680 - Apatinib (3-month supply, 500 mg/day): $390–$450 - Liver function panel + AFP + CEA: $45–$65
Surgical / Procedural / Interventional Options
*All procedures performed by interventional radiology specialists in tumor interventional departments.*
- •Transarterial Chemoembolization (TACE)
- *Procedure Cost (USD):* - Standard TACE (epirubicin + lipiodol + gelatin sponge): $1,250–$1,850 - DEB-TACE (DC Bead® 100–300 µm): $2,100–$3,400 - *Preoperative Workup (mandatory):* - Contrast-enhanced MRI/CT liver + angiogram planning: $220–$310 - Coagulation panel + renal function + CBC: $55–$80 - ECG + chest X-ray: $35–$50
- •Radioembolization (Y-90)
- *Procedure Cost (USD):* - Y-90 resin microspheres (SIR-Spheres®): $4,900–$6,700 - Y-90 glass microspheres (TheraSphere®): $5,300–$7,100 - *Preoperative Workup:* - Technetium-99m MAA scan + SPECT/CT quantification: $380–$520 - Hepatic arterial anatomy mapping angiogram: $450–$620
Special / Complex Condition Options
- •Combined TACE + Ablation (e.g., microwave ablation)
- *Cost (USD):* $2,800–$4,300 (includes both procedures, same-day admission)
- •Portal Vein Stent + TACE (for tumor thrombus)
- *Cost (USD):* $3,600–$5,200 (stent + embolization + anticoagulation monitoring)
Quick Selection Guide
- •Elderly (>75 yrs) / High Comorbidity Burden: Start with TAE + apatinib ($1,035–$1,445 total) — avoids chemotherapy toxicity and complex embolization.
- •Younger Patients (<65 yrs) / Intermediate-Stage HCC: Standard TACE ($1,525–$2,315) offers best cost-efficacy ratio with proven survival benefit.
- •Budget-Constrained (<$2,000 USD): Prioritize TAE + systemic therapy, omitting drug-eluting beads.
- •Liver-Dominant mCRC / Refractory HCC: Y-90 radioembolization ($5,280–$7,620) provides superior progression-free survival despite higher upfront cost.
- •Large Tumor with Portal Vein Invasion: Portal vein stent + TACE is the only curative-intent interventional option — justified despite $3,600+ investment.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Tumor Interventional Therapy Medical Vacation Packages
Curated transparent all-inclusive packages combining Tumor Interventional Therapy treatment with China top medical destinations:
